Company Overview and News

2
America's New Multipronged Foreign Policy

2018-09-20 seekingalpha
The economy is heating up. The second quarter GDP was revised upward to 4.2% from 4.1%. Walmart (NYSE:WMT), the nation's largest retailer, reported second quarter sales of $128 billion and same-store sales growth of 4.5% - the highest growth rate in ten years, demonstrating that the economic pick-up is being felt by most Americans. The stock market is pushing higher despite high valuations and plans by the Federal Reserve to unwind its massive Financial Crisis accommodation.
AMID EPD WMT

16
Fredrik Followers Favored 40 As Most Mentioned September Equities And Funds

2018-09-20 seekingalpha
August 15-September 17, Fredrik Arnold "followers" mentioned 40 equities & funds in their comments and suggestions. Some lamented bad news, so bad news investments mixed in with their favorites.
ARLP GIS AMID KWH.UN VOD VOD CRIUF ORC CNSL TYG CJREF CIM GMLP VODPF CJR.B CBL SNMP

16
Fredrik Followers Favored 40 As Most Mentioned September Equities & Funds

2018-09-20 seekingalpha
August 15-September 17, Fredrik Arnold "followers" mentioned 40 equities & funds in their comments and suggestions. Some lamented bad news, so bad news investments mixed in with their favorites.
ARLP GIS AMID KWH.UN VOD VOD CRIUF ORC CNSL TYG CJREF CIM GMLP VODPF CJR.B CBL SNMP

3
Your 80 Mid-September 10%+ Dividend WallStars By Yield And Target Gains

2018-09-18 seekingalpha
WallStars have positive broker target price upsides. 80 stocks displayed 10%+ forward yield, $2.00+ prices, and $50M+ market caps as of 9/14/18. Yields above 12.2% narrowed the list to 30.
AMID AIC MMLP NAP PER HCLP CCLP AI GMLP MDLY AIW USDP SNMP

5
10 Energy Sector Top Target Gains Range 24.6%-83.8% From September Dividend WallStars

2018-09-07 seekingalpha - 1
Energy equities with over .72% Broker Target Upsides showed midstream firms tops on the list, Sanchez, for price upside and American Midstream for net gains, and yield as of 9/6/18.
NGL AMID SNP MMLP SMLP BPL CCLP ETP SNP USAC GPP CVRR ENBL SNMP

9
10 Oil Stocks That Are Worth a Second Look

2018-09-05 investorplace - 1
The last few weeks have been tricky ones for energy investors. Some oil stocks have struggled, while others have managed to rally. The market has taken each of these names on a case-by-case basis.
APC AMID KML XOM SRCI CTLR MDR EPD EQT KMI EGN CLR KMR CVB KMRFZ AEUA MCDFF FANG

4
78 September 10%-Plus Dividend WallStars By Yield And Target Gains

2018-09-04 seekingalpha
WallStars show positive broker target price upsides. 78 stocks displayed 10%+ forward yield, $2.50+ prices, and $50M+ market caps as of 8/31/18. Yields above 12.19% narrowed the list to 30.
JE AMID AIC MMLP NAP PER JE AI GMLP MDLY AIW USDP SNMP

 
American Midstream to Acquire Interest in Enterprise's Plant

2018-08-24 zacks
Enterprise Products Partners L.P. (EPD - Free Report) and American Midstream Partners, LP (AMID) have inked an agreement. Per the terms, American Midstream may opt to acquire a 25% interest in Enterprise’s Pascagoula natural gas processing plant. The purchase option may be exercised on fulfillment of certain conditions, which include the completion of alterations to certain facilities on High Point pipeline system by American Midstream.
HLX TCP AMID EPD

3
Q2 '18 Recap And The Barbell Profile Of MLP Distribution Growth

2018-08-22 seekingalpha
For context, 2Q18 distributions refer to the distributions that will be paid in 3Q18 as a result of operational performance in 2Q18. The pie charts below reflect the Q/Q changes to distributions, comparing 2Q18 with 1Q18. For this exercise, we included Williams Partners (former ticker WPZ), which declared a distribution on July 23rd with a record date of August 3rd and was subsequently removed from both indices due to its merger with Williams Companies Inc.
BKEP AMID RMP EPD ALJ SEP ANDX HCLP AM GNE EQM WPZ WMB MMP PAA GEL MPLX VNOM PSXP TCP ALDW SHLX DM WES CVRR SPH GNE NS

6
Reader Comments Boosted 37 Dividend Stocks And Funds For August

2018-08-21 seekingalpha
From July 15 through Aug. 15, Fredrik Arnold "followers" mentioned 37 equities and funds in their comments and suggestions.
ARLP GIS AMID HMLP LMRK CIFAF ROYT ASHFP AHT.WI CAPL CJR.B AMZA PSEC FRO LMRKO VGR CJREF GMLP LMRKP CIX PBB AHT

 
AMID / American Midstream Partners LP / Magnolia Infrastructure Holdings, Llc - SC 13D AMENDMENT NO. 21 (Activist Investment)

2018-08-20 sec.gov
SC 13D Amendment No. 21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D
AMID

 
AMID / American Midstream Partners LP / Magnolia Infrastructure Holdings, Llc - SC 13D AMENDMENT NO. 21 (Activist Investment)

2018-08-20 sec.gov
SC 13D Amendment No. 21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D
AMID

16
No Encore, Deck Still Stacked For Midstream

2018-08-19 seekingalpha
The string of successive positive weeks for midstream ended this week. Midstream stocks were down roughly 1% across MLP and midstream indexes. Canadian Midstream stocks outperformed for the first time in a while. Utilities had a very strong week and the S&P was slightly positive. Oil prices continue to languish, now down 7 straight weeks, while natural gas prices continue to hold firm.
TGE CQP AMID PAGP ENB CEQP HCLP KMI HESM DKL TRP EBBNF OKE PAA ED KMR CVB NEE ENBBF TRP KEYUF LNG GLPRU ENLC ENB GBNXF ETP GLP SEMG TRGP KMRFZ

2
A Well Covered 7.1% Yield From A Deeply Hated Growth Stock

2018-08-15 seekingalpha
Few market sectors are as despised as the midstream sector. The ETRACS 2xMonthly Leveraged Alerian MLP Infrastructure Index ETN Series B (MLPQ) bottomed at $25.63 on 3/27/2018. Despite the historic bull market, this was a 2 year drop of about 50%. Midstream has suffered despite soaring U.S. oil and natural gas production which should favor pipelines and other infrastructure required to process and transport it.
AMID KMI EPD SXE KMR KMRFZ CVB

 
AMID / American Midstream Partners LP 10-Q (Quarterly Report)

2018-08-14 sec.gov
Document UNITED STATES
AMID

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to AMID / American Midstream Partners LP on message board site Silicon Investor.

Laramide Resources Ltd (LAM.V) Laramide Resources Ltd (LAM.V) Laramide Resources Ltd (LAM.V) Pyramid That IPO Pyramid That IPO Pyramid That IPO
Laramide Resources, Great New Property Laramide Resources, Great New Property Laramide Resources, Great New Property www.stockgeneration.com -- Pyramid Scam www.stockgeneration.com -- Pyramid Scam www.stockgeneration.com -- Pyramid Scam
PYRAMID ENERGY INC (PYI.A) PYRAMID ENERGY INC (PYI.A) PYRAMID ENERGY INC (PYI.A) Laramide Resources (T.LAM) Laramide Resources (T.LAM) Laramide Resources (T.LAM)
CUSIP: 02752P100